Improving Drug Response Predictions in Breast Cancer with RNA Editing
Author Information
Author(s): Bernal Yanara A., Blanco Alejandro, Oróstica Karen, Delgado Iris, Armisén Ricardo
Hypothesis
Integrating RNA editing data with traditional omics data can enhance machine learning models for predicting drug responses in breast cancer patients.
Conclusion
Incorporating RNA editing into predictive models could enhance personalized treatment strategies for breast cancer patients.
Supporting Evidence
- RNA editing data improved the performance of the random forest model for predicting drug response.
- The final model achieved an F1 score of 0.96 and an AUC of 0.922.
- A nonresponse risk score was developed based on RNA editing site patterns.
Takeaway
This study shows that using RNA editing information can help doctors better predict how breast cancer patients will respond to treatments.
Methodology
The study analyzed data from 104 breast cancer patients, using various machine learning models to predict drug responses based on clinical and omics data.
Participant Demographics
The cohort included 69 nonresponders and 35 responders to therapy.
Statistical Information
Confidence Interval
95% CI: 0.957--0.961
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website